ArticleOncoTargets and therapy2022

Long-Term Treatment-Free Survival After Multimodal Therapy in a Patient with Stage IV Lung Adenocarcinoma.

Hatsuyo Takaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.